Identification of novel phosphoproteomic biomarkers in patients with advanced hepatocellular carcinoma (HCC).

肝细胞癌 医学 生物标志物 肝硬化 癌症 Glypican 3型 内科学 肿瘤科 生物标志物发现 脂肪变性 癌症研究 蛋白质组学 病理 生物 基因 生物化学
作者
Debashis Sarker,Federico Pedicona,Yoh Zen,Weronika E. Borek,Shirin Elizabeth Khorsandi,Josie A. Christopher,Christina Karampera,Thomas Dowe,Nigel Heaton,Pedro R. Cutillas,Arran Dokal,David J. Britton
出处
期刊:Journal of Clinical Oncology [Lippincott Williams & Wilkins]
卷期号:41 (16_suppl): e15155-e15155
标识
DOI:10.1200/jco.2023.41.16_suppl.e15155
摘要

e15155 Background: HCC is one of the leading causes of cancer deaths worldwide. Despite increasing systemic therapy options for patients with advanced HCC, there are currently no predictive biomarkers to guide therapy selection. Phosphoproteomics has been successfully used to identify accurate predictive biomarkers in other cancers from frozen clinical samples (Dokal et al., 2021 ASCO Annual Meeting). In this study, we test the feasibility of biomarker discovery using phospho- and whole-proteomics analyses on formalin fixed and paraffin embedded (FFPE) tru-cut liver biopsies from patients with HCC. Methods: FFPE tru-cut biopsies (n = 29) were obtained from separate cohorts of 15 HCC patients [tumor (T)] and 14 patients with chronic liver disease with varying levels of cirrhosis, fibrosis or steatosis but without cancer [non-tumor (NT)]. T samples were from advanced HCC patients with varied aetiology (chronic viral hepatitis, alcohol or NAFLD). Proteins were extracted from 10 x 10µm sections; crosslinks reversed before digestion to peptides; and multiple clean-up/enrichment steps before analysis. Peptides were quantified by mass spectrometry and performance assessed using multi-variate and enrichment analyses. Results: Overall, 4978 phosphopeptides and 3721 proteins were quantified across all samples. Multi-variate analyses based on the relative expression of phosphopeptides or proteins showed a clear separation between T and NT samples, as well as phenotype-distinct separation (i.e according to differentiation) within the T group. Subsequent testing also verified that the method could reproducibly measure these HCC-differentiating phosphorylation sites (and proteins). Proteins associated with HCC were regulated as expected in T vs NT, e.g. ASS1 (log2-fold change (FC) = -1.75, p < 0.001), BDH2 (log2-FC = -1.97, p < 0.001). Known drug targets were found to be significantly upregulated in poorly-differentiated HCC, e.g. PARP1 (log2-FC = 1.7, p < 0.001) and AKT1 (log2-FC = 1.5, p < 0.001), as well as previously described phosphorylation sites, e.g. p-CDK1 T14 (log2-FC = 5.95, p = 0.007) and p-MCM2 S139 (log2-FC = 2.98, p = 0.046). Kinase substrate enrichment analysis (Casado et al., Science Signaling 2013) showed increased activity for several kinases in T vs NT, including A-RAF (z-score = 3.2, p < 0.001), MAPK3 (z-score = 2.1, p = 0.022) and TNK2 (z-score = 2.1, p = 0.003). Conclusions: We successfully adapted (phospho-)proteomics to FFPE tru-cut biopsy specimens, enabling reproducible identification of novel and known (phospho-)proteins that distinguished differentiation status. A prospective study utilising this phosphoproteomic analysis pipeline is now underway, recruiting patients with advanced HCC receiving first line standard of care therapy with immune checkpoint inhibitor combinations or tyrosine kinase inhibitors to identify potential predictive biomarkers of response.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
AireenBeryl531的应助被精明怜南采纳,获得10
刚刚
1秒前
eeven的应助被Tuniverse_采纳,获得10
1秒前
1秒前
菜菜彼得发布了新的文献求助10
1秒前
nn发布了新的文献求助10
1秒前
buryall完成签到,获得积分20
1秒前
li发布了新的文献求助30
2秒前
逸晨完成签到 ,获得积分10
2秒前
对先生完成签到 ,获得积分10
2秒前
3秒前
沉静鼠鼠完成签到 ,获得积分10
3秒前
熊猫海发布了新的文献求助10
3秒前
cassie完成签到,获得积分10
4秒前
4秒前
Libgenxxxx完成签到,获得积分10
4秒前
4秒前
4秒前
5秒前
ASDF完成签到,获得积分10
5秒前
5秒前
华仔的应助被王灌灌灌灌采纳,获得20
5秒前
Skotty完成签到,获得积分10
5秒前
随意发布了新的文献求助10
5秒前
yoimiya完成签到,获得积分10
6秒前
Jennifer发布了新的文献求助10
6秒前
Ag发布了新的文献求助10
6秒前
zz发布了新的文献求助10
6秒前
干净的尔岚完成签到,获得积分10
6秒前
lei完成签到,获得积分10
6秒前
Lucas的应助被cherish采纳,获得10
7秒前
荒天帝完成签到 ,获得积分10
7秒前
7秒前
8秒前
糟糕的冷雪完成签到,获得积分10
8秒前
9秒前
9秒前
烟花的应助被XQ采纳,获得10
9秒前
lu完成签到,获得积分20
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8182238
求助须知:如何正确求助?哪些是违规求助? 9571879
关于积分的说明 21820474
捐赠科研通 7778782
什么是DOI,文献DOI怎么找? 3433645
关于科研通互助平台的介绍 2557824
邀请新用户注册赠送积分活动 2479666